C07D 471 - Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups

Patents for C07D 471 - Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups (64,559)
12/2002
12/10/2002	US6492390 Treating cyclooxygenase-2 mediated disorders.
12/10/2002	US6492384 Imidazo (4,5-C) pyridine-4-one derivatives with factor XA inhibiting effect
12/10/2002	US6492382 Dried or frozen pharmaceutical preparation containing a class III antiarrhythmic compound
12/10/2002	US6492374 Benzofuran derivatives, their preparation and use
12/10/2002	US6492367 Sulfamato hydroxamic acid metalloprotease inhibitor
12/10/2002	US6492366 Cyano-indole serotonin-reuptake inhibitor compound
12/10/2002	US6492364 Triazolo and derivatives as chemokine inhibitors
12/10/2002	US6492358 For treatment of sexual disorders, male erectile dysfunction
12/10/2002	US6491847 Discotic liquid crystal and organic electroluminescence device using same
12/10/2002	US6491749 Fluorescent dyes having good fastness to heat and to light
12/10/2002	CA2092431C 3,9-diazabicyclo (3.3.1) nonan-7-yl derivatives, process and intermediates for their preparation and pharmaceutical compositions containing them
12/09/2002	WO2002004403A1 Biphenylcarboxylic acid amides, production thereof and use thereof as medicaments
12/09/2002	CA2412116A1 Biphenylcarboxylic acid amides, the preparation thereof and the use thereof as medicaments
12/05/2002	WO2002096911A1 Novel heteroaryl-diazabicyclo-alkanes as cns-modulators
12/05/2002	WO2002096908A1 Antibacterial agents
12/05/2002	WO2002096907A1 Bicyclic nitrogen-containing heterocyclic derivatives for use as antibacterials
12/05/2002	WO2002096516A1 Use of compositions comprising cyclooxygenase-2 selective inhibitors in combination with radiation for inhibition or prevention of cardiovascular disease
12/05/2002	WO2002096463A1 A pde 4 inhibitor and an anti-cholinergic agent in combination for treating obstructive airways diseases
12/05/2002	WO2002096426A1 Hydantion derivatives as inhibitors of matrix metalloproteinases
12/05/2002	WO2002096423A2 Combination of a pde4 inhibitor and tiotropium or derivate thereof for treating obstructive airways
12/05/2002	WO2002096418A1 Pirenzepine ophthalmic gel
12/05/2002	WO2002096318A2 Method for treating glaucoma v
12/05/2002	WO2002078693A3 N-(2-arylethyl)benzylamines as antagonists of the 5-ht6 receptor
12/05/2002	WO2001093840A2 Ligands of integrin receptors
12/05/2002	US20020183523 Cis-substituted aminocyclopropane derivative
12/05/2002	US20020183522 Reacting benzoylamide compound with 2-aminopyridine derivative
12/05/2002	US20020183520 Process to prepare (5R)-(methylamino)-5,6-dihydro-4H-imidazo[4,5,1-ij]-quinolin-2(1H)-one
12/05/2002	US20020183518 Use for treatment of human and animal disorders, for purification of proteins or glycoproteins, and in diagnosis
12/05/2002	US20020183375 For therapy of depression, anxiety, affective disorders, feeding disorders, post-traumatic stress disorder, headache, drug addiction, inflammatory disorders, drug or alcohol withdrawal symptoms
12/05/2002	US20020183364 Methods of modulating protein tyrosine kinase function with substituted indolinone compounds
12/05/2002	US20020183346 Tricyclic androgen receptor modulator compounds and methods
12/05/2002	US20020183342 For use as insecticides against a variety of insects, including larvae, such as tobacco budworm
12/05/2002	US20020183327 For use as analgesics
12/05/2002	US20020183326 1,2,4-triazolo[4,3-B]pyrido[3,2-D]pyridazine derivatives and pharmaceutical compositions containing them
12/05/2002	US20020183320 For use as analgesics
12/05/2002	US20020183319 For therapy of blood vessel proliferative disorders; fibrotic disorders; mesangial cell proliferative disorders; metabolic disorders; allergies; asthma; thrombosis; nervous system diseases; and cancer
12/05/2002	US20020183307 For therapy of hyperlipidemic condition
12/05/2002	CA2448363A1 Combination of a pde4 inhibitor and tiotropium or derivate thereof for treating obstructive airways
12/05/2002	CA2448317A1 Method for treating glaucoma v
12/05/2002	CA2447657A1 Use of compositions comprising cyclooxygenase-2 selective inhibitors in combination with radiation for inhibition or prevention of cardiovascular disease
12/05/2002	CA2447562A1 Pirenzepine ophthalmic gel
12/05/2002	CA2447475A1 Hydantion derivatives as inhibitors of matrix metalloproteinases
12/05/2002	CA2446697A1 Antibacterial agents
12/05/2002	CA2446613A1 A pde 4 inhibitor and an anti-cholinergic agent in combination for treating obstructive airways diseases
12/05/2002	CA2411549A1 Ligands of integrin receptors
12/04/2002	EP1262477A1 Anti-acid-fast bacterial agents containing pyridonecarboxylic acids as the active ingredient
12/04/2002	EP1262195A1 Vasoactive agents
12/04/2002	EP1261630A2 Bacterial genes and proteins that are essential for cell viability and their uses
12/04/2002	EP1261610A2 Succinoylamino carbocycles and heterocycles as inhibitors of a-beta protein production
12/04/2002	EP1261608A1 Diketopiperazine derivatives to inhibit thrombin
12/04/2002	EP1261607A1 2,4-disubstituted thiazolyl derivatives
12/04/2002	EP1111993A4 Fused-benzene derivatives useful as herbicides
12/04/2002	EP1077967B1 Biphenyl oxo-acetic acids useful in the treatment of insulin resistance and hyperglycemia
12/04/2002	EP0703791B1 An iodinated neuroprobe for mapping monoamine reuptake sites
12/04/2002	CN1383427A Process for preparing N6-substituted deaza-adenosine derivatives
12/04/2002	CN1383425A Uracil substituted phenyl sulfamoyl carboxamides
12/03/2002	US6489488 Serotonin (5-ht) subtype 6 receptor (5-ht6); 3-(2-aminoethyl)indole derivatives; drug screening
12/03/2002	US6489374 Organonitrogen compounds that yield amines, imines or amidines when exposed to visible or ultraviolet radiation; polymerization catalysts used in one-pot systems having storage stability
12/03/2002	US6489338 Imidazopyridine and imidazopyrimidine antiviral agents
12/03/2002	US6489337 Treatment of alzheimer's disease, epilepsy, eating disorders, learning and memory disorders, migraine, sleep/wake disorders, allergic rhinitis, schizophrenia, mild cognitive impairment, and asthma
12/03/2002	US6489333 Heterocyclic compounds containing a guanidine mimic, for inhibition of cell adhesion, treatment of angiogenesis disorders, inflammation, cancer metastasis, diabetic retinopathy, thrombosis, restenosis, macular degeneration
12/03/2002	US6489315 Cyclic compounds, their production and use
12/03/2002	CA2266107C Aralkyl and aralkylidene heterocyclic lactams and imides
12/03/2002	CA2263500C Malonate derivatives useful as intermediates for producing isoxazolidinadione hypoglycemic agents
12/03/2002	CA2080705C Substituted pyrimidines
12/03/2002	CA2065644C Pyrazolopyridine compound and processes for preparation thereof
11/2002
11/28/2002	WO2002094840A2 Tricyclic dihydro-quinoline derivatives, method for preparing same and pharmaceutical compositions containing same
11/28/2002	WO2002094833A1 Novel pyrrole derivatives as pharmaceutical agents
11/28/2002	WO2002094830A2 DIHYDROPYRROLO[1,2-A]INDOLE AND TETRAHYDROPYRIDO[1,2-a]-INDOLE DERIVATIVES AS PROSTAGLANDIN D2 RECEPTOR ANTAGONISTS
11/28/2002	WO2002094827A1 Fused tropane derivatives and their use as monoamine neurotransmitter re-uptake inhibitors
11/28/2002	WO2002094826A1 Tri-and tetraaza-acenaphthylen derivatives as crf receptor antagonists
11/28/2002	WO2002094825A1 Novel spiropiperidine derivative
11/28/2002	WO2002094824A1 Pyridopyrimidine compounds and their uses
11/28/2002	WO2002094823A1 1-biaryl-1,8-napthyridin-4-one phosphodiesterase-4 inhibitors
11/28/2002	WO2002094822A1 Uronium and immonium salts for peptide coupling
11/28/2002	WO2002094814A1 3,5-diamino-1,2,4-triazoles as kinase inhibitors
11/28/2002	WO2002094809A1 3-quinoline-2-(1h)-ylideneindolin-2-one derivatives
11/28/2002	WO2002094799A2 Melanin concentrating hormone receptor ligands: substituted 1-benzyl-4-aryl piperazine analogues
11/28/2002	WO2002094790A1 Fused heterocyclic compound and medicinal use thereof
11/28/2002	WO2002094236A1 Delivery of antipsychotics through an inhalation route
11/28/2002	WO2002094197A2 Bicyclic inhibitors of factor xa
11/28/2002	WO2002085896A8 Antidepressant azaheterocyclylmethyl derivatives of 2,3-dihydro-1,4-benzodioxan
11/28/2002	WO2001089497A3 Praziquantel compositions for treating diseases due to sarcocystis, neospora, toxoplasma and isospora
11/28/2002	US20020177713 1,4,5,6-tetrahydropyrazolo-[3,4,-c]-pyridin-7-ones useful as factor Xa inhibitors
11/28/2002	US20020177604 N-(4-chlorobenzyl)-6-(3-hydroxy-1-propynyl)-1-7-dimethyl-4-oxo-1,4 -dihydro(1,8)naphthyridine-3-carboxamide for example; inhibiting viral DNA polymerase; treating herpes virus infections
11/28/2002	US20020177603 5,10-dihydrobenzo(b)(1,8)naphthyridine compounds, N-oxides; 3,7-Dichloro-5-isopropoxymethyl-5-trifluoromethyl-5,10 -dihydrobenzo(b)(1,8)naphthyridine for example; combination therapy
11/28/2002	US20020177600 Two or more ligand moieties covalently linked together by one or more linking groups enabling binding to multiple binding sites; increased efficacy, selectivity and duration; anti-proliferative and anticarcinogenic
11/28/2002	US20020177593 Non-carbamate amine acetylcholinesterase inhibitor and a carrier; for example, 9-amino-1,2,3,4-tetrahydroacridine or 8-(3-(1-((3-fluorophenyl)methyl)-4-piperidinyl)-1-oxopropyl)-1,2,5,6 -tetrahydro-4H-pyrrolo(3,2,1-ij)quinolin-4-one
11/28/2002	US20020177591 Central nervous system (CNS); diazabicyclo compounds such as 1,4-Diaza-bicyclo(3.2.2)nonane-4-carboxylic acid, 4-cyclohexyl-phenyl ester; CNS-penetrant alpha 7 nicotinic receptor agonist
11/28/2002	US20020177587 Treating sexual dysfunction including erectile dysfunction, diabetes melitus, gastrointestinal disorders, including gastric paresis and cardiovascular disorders; cyclic guanosine 3',5'-monophosphate (cGMP)
11/28/2002	US20020177559 Inhibitors of cellular efflux pumps of microbes
11/28/2002	DE10123586A1 New 3,5-diamino-1,2,4-triazole derivatives, are cyclin dependent kinase inhibitors useful for treating e.g. cancer, autoimmune, cardiovascular or neurodegenerative diseases or viral infections
11/28/2002	CA2450535A1 Tri-and tetraaza-acenaphthylen derivatives as crf receptor antagonists
11/28/2002	CA2448531A1 Uronium and immonium salts for peptide coupling
11/28/2002	CA2448197A1 Tricyclic dihydro-quinoline derivatives, method for preparing same and pharmaceutical compositions containing same
11/28/2002	CA2448080A1 Melanin concentrating hormone receptor ligands: substituted 1-benzyl-4-aryl piperazine analogues
11/28/2002	CA2448076A1 3-quinoline-2-(1h)-ylideneindolin-2-one derivatives
11/28/2002	CA2447488A1 Bicyclic inhibitors of factor xa
11/27/2002	EP1260512A1 Novel cyclic amide derivatives
11/27/2002	EP1259520A2 Novel purines

1 ... 436 437 438 439 440 441 442 443 444 445 446 447 448 449 450 451 452 453 454 455 456 ... 646